Filtered By:
Source: JNCI
Drug: Tamoxifen
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Risk-Benefit Profiles of Women Using Tamoxifen for Chemoprevention
Conclusions:
While the majority of women who used tamoxifen for primary prevention of breast cancer were likely to benefit, substantial discontinuation of tamoxifen before five years and use by women at risk of serious side effects may attenuate benefits for breast cancer prevention.
Source: JNCI - December 3, 2014 Category: Cancer & Oncology Authors: Nichols, H. B., DeRoo, L. A., Scharf, D. R., Sandler, D. P. Tags: Article Source Type: research
